Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT03076242 · ClinicalTrials.gov registry record
Genetic Evaluation of Men (GEM)
A clinical trial, sponsored by Sidney Kimmel Comprehensive Cancer Center at Thomas Jefferson University.
- Terminated
- Registry status
- 595
- Enrollment target
NCT03076242 is a clinical trial that was terminated before completion, run by Sidney Kimmel Comprehensive Cancer Center at Thomas Jefferson University. The registered enrollment target is 595 participants.
The verdict
NCT03076242 was terminated before completion, sponsored by Sidney Kimmel Comprehensive Cancer Center at Thomas Jefferson University.
- TERMINATED
- Registry status
- 595 participants
- Enrollment target
Study Summary
This is a prospective research registry and prospective genetic testing cohort study. The goal is to collect personal medical and cancer history data, family cancer data, exposure history, and biospecimens to support research focused on optimal genetic testing strategies for men with prostate cancer with the ultimate goal of informing national guidelines focused on genetic evaluation for prostate cancer.
Interventions
- OTHER GEM Registry
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 595 participants |
| Start Date | 2014-10-23 |
| Est. Completion | 2019-05-16 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT03076242
The ClinicalTrials.gov registry entry for NCT03076242 describes a study currently listed as terminated, categorized as an unspecified phase. The registered enrollment target is 595 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Sidney Kimmel Comprehensive Cancer Center at Thomas Jefferson University, which has 138 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 1 intervention - of which GEM Registry is the first listed.
NCT03076242 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT03076242 about?
NCT03076242 is a clinical study titled "Genetic Evaluation of Men (GEM)". This is a prospective research registry and prospective genetic testing cohort study. The goal is to collect personal medical and cancer history data, family cancer data, exposure history, and biospecimens to support research focused on optimal genetic testing strategies for men with prostate cancer...
What is the current status of trial NCT03076242?
This trial is currently terminated. The enrollment target is 595 participants. The study started on 2014-10-23. Estimated completion is 2019-05-16.
What interventions are being tested in trial NCT03076242?
The interventions under investigation include: GEM Registry (OTHER).
Who is sponsoring clinical trial NCT03076242?
This trial is sponsored by Sidney Kimmel Comprehensive Cancer Center at Thomas Jefferson University, which has 138 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.